Is There a Future for PARP Inhibitors in Ovarian Cancer?
PARP inhibitors are promising agents, particularly for cancers associated with BRCA gene mutations.
Does IVF Cause an Increased Risk of Cancer?
A recent study addressed the cancer risks associated with in vitro fertilization (IVF).
Addressing Chemotherapy Induced Ovarian Failure in Patients With Breast Cancer
One of the biggest quality of life issues affecting young women treated with chemotherapy for breast cancer is chemotherapy induced ovarian failure.
Save The Date: The National Consortium of Breast Centers 2011 Meeting
The National Consortium of Breast Centers next annual meeting is March 12-16, 2011. The meeting will feature a special opening plenary session.
Preserving Future Fertility: The Artificial Ovary
Researchers at Brown University have built an artificial human ovary that can grow oocytes into mature human eggs in the laboratory.
What Do I Do Now?
The treatment of locally advanced breast cancer that does not completely resolve following neoadjuvant chemotherapy is unclear.
Curing HER-2 positive breast cancer?
Results from the San Antonio Breast Cancer Symposium in December 2009 show that at 5 years, more than 80% of women treated with adjuvant trastuzumab on the NCCTG trial are still disease free.
Hope for Patients with BRCA-mutation Associated Cancer
One of the best characterized genetic mutations associated with an increased risk of cancers of the breast, ovary, prostate, and others involves the BRCA-genes.
ASCO Update: Part 2
It's been about a month since ASCO and as I've gone through the research presented at the meeting related to women's cancer, it shows that there were exciting results shared with the attendees.
2 Clarke Drive Cranbury, NJ 08512